Detalles de la búsqueda
1.
A Phase 2 Proof-of-Concept, Randomized, Placebo-Controlled Trial of CX-8998 in Essential Tremor.
Mov Disord
; 36(8): 1944-1949, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33764619
2.
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques.
Mov Disord
; 34(5): 708-716, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30575996
3.
Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects.
Br J Clin Pharmacol
; 84(10): 2422-2432, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29959802
4.
Characterizing patient compliance over six months in remote digital trials of Parkinson's and Huntington disease.
BMC Med Inform Decis Mak
; 18(1): 138, 2018 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30572891
5.
Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration.
Neurodegener Dis
; 18(5-6): 262-269, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30453303
6.
Technology in Parkinson's disease: Challenges and opportunities.
Mov Disord
; 31(9): 1272-82, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27125836
7.
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine.
BMC Neurol
; 15: 100, 2015 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26133547
8.
Clinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studies.
Front Neurol
; 15: 1320663, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38529036
9.
Biomarkers associated with migraine and their potential role in migraine management.
Headache
; 53(8): 1262-77, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23848170
10.
Reversal of Bortezomib-Induced Neurotoxicity by Suvecaltamide, a Selective T-Type Ca-Channel Modulator, in Preclinical Models.
Cancers (Basel)
; 13(19)2021 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638498
11.
Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development.
Front Neurol
; 12: 788168, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35185751
12.
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of CX-8998, a Selective Modulator of the T-Type Calcium Channel in Inadequately Treated Moderate to Severe Essential Tremor: T-CALM Study Design and Methodology for Efficacy Endpoint and Digital Biomarker Selection.
Front Neurol
; 10: 597, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31244760
13.
Quantification of Motor Function in Huntington Disease Patients Using Wearable Sensor Devices.
Digit Biomark
; 3(3): 103-115, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32095771
14.
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.
Lancet Neurol
; 18(2): 165-176, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30563778
15.
The First Frontier: Digital Biomarkers for Neurodegenerative Disorders.
Digit Biomark
; 1(1): 6-13, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-32095743
16.
Biometric Digital Health Technology for Measuring Motor Function in Parkinson's Disease: Results from a Feasibility and Patient Satisfaction Study.
Front Neurol
; 8: 273, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28659858
17.
Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action.
Clin Ther
; 39(5): 1064-1076, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28413148
18.
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease.
Sci Rep
; 6: 31652, 2016 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27528441
19.
Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention.
PM R
; 7(1): 60-7, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25171879
20.
Psychiatric comorbidities of episodic and chronic migraine.
J Neurol
; 260(8): 1960-9, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23132299